Qing Zhang
Global Molecular Design and Informatics, Merck Research Laboratories, USA
Ada Solidar
VaSSA Informatics, USA
Nicholas J. Murgolo
Global Molecular Design and Informatics, Merck Research Laboratories, USA
Wynand Alkema
Global Molecular Design and Informatics, Merck Research Laboratories, USA
Wei Ding
Global Molecular Design and Informatics, Merck Research Laboratories, USA
Peter M. Groenen
Global Molecular Design and Informatics, Merck Research Laboratories, USA
Jonathan R. Greene
Global Molecular Design and Informatics, Merck Research Laboratories, USA
Eric L. Gustafson
Functional Genomics, MRL, USA
Jan Klomp
Global Molecular Design and Informatics, Merck Research Laboratories, USA
Ellie D. Norris
Global Molecular Design and Informatics, Merck Research Laboratories, USA
Ping Qiu
Global Molecular Design and Informatics, Merck Research Laboratories, USA
Gerald J. Wyckoff
UMKC SBS, Division of Molecular Biology and Biochemistry, Kansas City, Mo, USA
LiveDNA: 1.30879
PDF Fulltext XML References Citation
How to cite this article
Qing Zhang, Ada Solidar, Nicholas J. Murgolo, Wynand Alkema, Wei Ding, Peter M. Groenen, Jonathan R. Greene, Eric L. Gustafson, Jan Klomp, Ellie D. Norris, Ping Qiu and Gerald J. Wyckoff, 2012. Selective Constraint: A Hallmark of Genes Successfully Targeted for Pharmaceutical Development. American Journal of Drug Discovery and Development, 2: 184-193.
DOI: 10.3923/ajdd.2012.184.193
URL: https://scialert.net/abstract/?doi=ajdd.2012.184.193
DOI: 10.3923/ajdd.2012.184.193
URL: https://scialert.net/abstract/?doi=ajdd.2012.184.193